ANDA 86213, held by Impax Labs. Chlordiazepoxide Hydrochloride.
As of Nov 16, 2026, ANDA 86213 (Chlordiazepoxide Hydrochloride), held by Impax Labs, was first approved by FDA on Jul 10, 1979, with 6 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 10, 1979 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Chlordiazepoxide Hydrochloride5MG ยท capsule;oral | Chlordiazepoxide Hydrochloride | Discontinued |
| Jan 10, 1992 | Supplement 6Labeling | Approved | None posted |
| Oct 9, 1991 | Supplement 5Labeling | Approved | None posted |
| Sep 17, 1991 | Supplement 4Labeling | Approved | None posted |
| Feb 4, 1991 | Supplement 2Labeling | Approved | None posted |
| Feb 4, 1991 | Supplement 3Labeling | Approved | None posted |
| Oct 24, 1989 | Supplement 1Labeling | Approved | None posted |
| Jul 10, 1979 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters